← Eichor
Study identifier: NCT06593314 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes

Condition: Heart Failure · Diabetes  ·  Sponsor: University of Texas Southwestern Medical Center

PhaseNA
Planned participants800
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

A pragmatic electronic health record (EHR) based randomized controlled trial to evaluate the utility of providing Ultromics EchoGo analysis results and recommendations for HF risk prevention therapies using an EHR embedded clinical decision support tool.

This description comes directly from the study's public registry record.

Talk to the study team

Ambarish Pandey, MD  ·  617-869-8957  ·  Ambarish.Pandey@UTSouthwestern.edu

Always discuss trial participation with your own doctor first.

Locations (1)

UT Southwestern Medical CenterDallas, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06593314